Skip to content

The Clinical Observation of the Analgesic Effect of Different Local Anesthetic Optimized Formulations for Incision Infiltration in Cesarean Section Patients

The Clinical Observation of the Analgesic Effect of Different Local Anesthetic Optimized Formulations for Incision Infiltration in Cesarean Section Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101948
Enrollment
Unknown
Registered
2025-05-06
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Group A1:Ropivacaine 75mg+Dexamethasone 5mg+Epinephrine 50ug+NS to 50 for incision infiltration (30ml)
Group C:PCIA—Sufentanil 150ug+5-HT3 receptor antagonist 1 vial+0.9% NS 150ml.
Group A0:Ropivacaine 75mg+Epinephrine 50ug+NS to 50 for incision infiltration (30ml)
Group A2:Ropivacaine 75mg+Dexmedetomidine 50ug+Dexamethasone 5mg Epinerine 50ug+NS to 50ml for incision infiltration (30ml)
Group A3:Ropivacaine 75mg+Dexmedetomidine 50ug+Ketorolac 30mg+ Dethasone 5mg+Epinephrine 50ug+NS to 50ml for incision infiltration (30ml)

Sponsors

Guizhou Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Emergency or elective cesarean section surgery, patients aged 18-50 years old, and received neuraxial anesthesia

Exclusion criteria

Exclusion criteria: 1. Unable to provide informed consent; 2. Unable to understand written or spoken language; 3. Severe comorbidities (such as severemonary hypertension, heart failure, etc.) 4. Contraindications to neuraxial anesthesia: low coagulation function; platelet count <80×10^9/L; pregnant women who refuse or cannot cooperate with the procedure; pregnant women with shock, hypovolemia, or other hemodynamic instability; pregnant women with severe deformities, trauma, etc., which may affect puncture; pregnant women with infection at the puncture site or bacteremia that could lead to neuraxial; pregnant women with central nervous system diseases, especially spinal cord or spinal nerve root lesions; other conditions that may lead to neuraxial bleeding or infection

Design outcomes

Primary

MeasureTime frame
Numerical Rating scale;

Secondary

MeasureTime frame
Postoperative opioid use within 72 hours;Postoperative opioid use within 30d;Time to Bowel Movement;Time to oral intake;Time to Ambulation;Post-operative Nausea and Vomiting;Length of hospitalization;Number of Participants With Readmission to the Hospital;Patient reported quality of recovery and quality of life as determined by QoR-15 score;Occurrence of severe and minor complications within 30 days postoperatively;Cost per patient;

Countries

China

Contacts

Public ContactKaiyun Fang

Guizhou Provincial People's Hospital

fangkaiyun@sina.cn+86 139 8553 3277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026